Specifications
Species Reactivity
Mouse; Rat; Human
Immunogen
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human NMT2. The exact sequence is proprietary.Database link: O60551
Applications
Application Notes
WB: 1/1000 - 1/2000; IHC-P: 1/100; ICC/IF: 1/500; Flow Cyt: 1/40;
Target
Alternative Names
NMT2; N-myristoyltransferase 2; glycylpeptide N-tetradecanoyltransferase 2; NMT 2; type II N-myristoyltransferase; peptide N-myristoyltransferase 2; myristoyl-CoA:protein N-myristoyltransferase 2;
Product Background
Antigen Description
Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins.
Pathway
Assembly of HIV virion, organism-specific biosystem; Disease, organism-specific biosystem; HIV Infection, organism-specific biosystem; HIV Life Cycle, organism-specific biosystem; Late Phase of HIV Life Cycle, organism-specific biosystem; Membrane binding and targetting of GAG proteins, organism-specific biosystem; Synthesis and organization of GAG, GAGPOL polyproteins, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-7020 in a publication?
Let us know and earn a reward for your research.